附註:Includes bibliographical references.
Challenges in Scaling up Treatment -- The economic impact of HIV/AIDS and ART -- Estimating resource requirements -- Long-term economic effect of HIV/AIDS and other considerations -- Intellectual Property Rights: A Concise Guide -- Introduction to this concise guide -- How patents affect medicines procurement -- Least developed countries -- Developing countries -- A note on "parallel imports" -- Registration and data exclusivity -- Managing the Supply Cycle for Better Outcomes -- Who does what? -- What tasks need to be done? -- Who is already carrying out these tasks? -- Monitoring procurement results -- Product Selection, Quantification, and Quality Assurance -- Product selection -- How drugs should be selected for HIV-related treatment -- Product quantification -- Quality assurance and supplier selection -- Testing and laboratory capacity -- Procurement -- Assessing capacity -- Commodities that support the HIV/AIDS program -- Planning procurement -- Registering products -- Choosing procurement methods -- Pricing -- What determines drug prices? -- Additional price determinants in retail markets -- How can public purchasers bargain for low prices? -- Estimating Resource Requirements for AIDS Treatment -- Intellectual Property Rights: How They Affect Procurement and What Steps Can Be Taken -- HIV Test Kits and Other Diagnostics.
摘要:This Guide sets out principles and advice for the procurement of HIV/AIDS medicines and related supplies for programs scaling up antiretroviral therapy (ART) and associated health services, such as basic and palliative care, disease prevention, treatment of opportunistic infections, and laboratory tests. ART includes the treatment of infected adults and children and the prevention of mother-to-child transmission. A wide range of other commodities-particularly condoms and support for basic living and care-are also essential to support the treatment and prevention of HIV. The primary audience for this guide is World Bank staff and those responsible for procuring HIV/AIDS medicines and related supplies in Bank-funded programs and projects-which could include either procurement agency staff or technical agency staff. Policymakers and Bank partners will also benefit from the information and advice in the guide.
